Guarana Stimulant Pouch Composition Without Nicotine Staining
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Nicotine pouches are highly addictive and harmful, causing health issues such as increased heart rate, blood pressure, and oral irritation, while caffeinated pouches are bitter and stain teeth.
Innovation Solution
An orally administered stimulant containing guarana extract, polyvinylpyrrolidone, xylitol sweetener, sucralose, natural flavoring, and mint extract, optionally with vitamins, formulated into a powder encased in a water-insoluble pouch that is permeable to saliva, providing a refreshing sensation and avoiding tooth staining.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nicotine pouches are used to deliver stimulants, then stimulant delivery is effective, but harmful effects on oral health and cardiovascular system occur
Solution Approach 1:
The patent extracts and removes nicotine from the pouch formulation, replacing it with alternative stimulants like caffeine and guarana extract. This eliminates the harmful addictive properties and oral health damage associated with nicotine while preserving the stimulant delivery function through other safe compounds.
Solution Approach 2:
The patent introduces food-grade ingredients and safe excipients as intermediaries between the stimulant delivery mechanism and the user's oral tissues. These materials serve as protective mediators that enable effective stimulant delivery without direct contact with harmful substances, thus protecting oral health.
2Reliability
If caffeinated pouches are used to deliver stimulants, then stimulant delivery is effective, but bitter taste and tooth staining occur
Solution Approach 1:
The patent converts the naturally bitter taste of caffeine into a benefit by combining it with sweetening agents and flavor compounds. This transformation maintains the stimulant effectiveness while masking the unpleasant bitter taste, and the formulation is designed to prevent tooth staining through careful selection of ingredients and their concentrations.
Solution Approach 2:
The patent creates a composite pouch formulation combining caffeine, guarana extract, sweeteners, and flavoring agents in specific proportions. This composite material delivers the stimulant effect while the combined ingredients work together to mask bitterness and prevent tooth staining, solving multiple problems simultaneously.
3Duration of action of stationary object
If nicotine pouches are used for long-term administration, then stimulant delivery is sustained, but severe oral mucosa irritation and inflammation occur
Solution Approach 1:
The patent removes nicotine from the formulation entirely, replacing it with non-irritating stimulants. This extraction eliminates the cause of severe oral mucosa irritation and inflammation that occurs with long-term nicotine use, while maintaining sustained stimulant delivery through alternative compounds that do not damage oral tissues.
Solution Approach 2:
The patent changes the chemical composition parameters of the pouch contents from nicotine-based to caffeine and guarana-based formulations. This parameter change fundamentally alters the interaction with oral mucosa from harmful and irritating to safe and non-irritating, while preserving the duration and effectiveness of stimulant delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The stimulant effectively delivers caffeine without the adverse effects of nicotine and bitterness, offering a refreshing experience and maintaining oral health.
Implementation Method 1
the water insoluble pouch may be permeable for saliva
Data Source
AI summary
An orally administered stimulant. The orally administered stimulant comprising at least 30% of guarana extract; at least 0.1% of polyvinylpyrrolidone; at least 0.1% of xylitol sweetener; at least 0.1% of sucralose; at least 0.1% of natural flavoring; and at least 0.1% of mint extract, wherein the orally administered stimulant is fully mixed into a homogonous solution and dried to form a powder.


